- Telehealth Visits
- Insurance plan information
Katsuto Shinohara, MD
Urologic Oncology- Telehealth Visits
- Insurance plan information
Katsuto Shinohara, MD
Urologic Oncology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Katsuto Shinohara specializes in urologic cancers, in particular prostate cancer. He has special interests in innovative biopsy techniques and image-guided minimally invasive treatments for prostate cancer, as well as in applying ultrasound techniques in the diagnosis, management and treatment of all urologic cancers.
Shinohara earned his medical degree from Yokohama City University School of Medicine in Yokohama, Japan. He completed a residency in general surgery at Mitsui Memorial Hospital in Tokyo, Japan, and a residency in urology at Kitasato University Hospital in Sagamihara, Japan. He then completed a fellowship in urologic oncology at Baylor College of Medicine in Houston, Texas.
Shinohara is a member of numerous professional societies, including the Japanese Urological Association, Japan Society of Ultrasonics in Medicine, American Institute of Ultrasound in Medicine, American Urological Association and Engineering & Urology Society. He has lectured widely on urologic cancer, and his work has been published in numerous medical and scientific journals.
Education & training
Fellowship
- Urologic Oncology, Baylor College of Medicine
Residency
- Urology, Kitasato University Hospital
- General Surgery, Mitsui Memorial Hospital
Degree
- MD, Yokohama City University
Academic title
- Clinical Professor
My expertise
Locations
My research
Publications
Showing 1-6 of 139 reviews
- April 24, 20265 out of 5 Stars
Eleven years ago, Dr. Shinohara performed a transurethral resection of the prostate (TURP) to treat my severe benign prostatic hyperplasia (BPH). After the procedure, my PSA levels dropped from 7 ng/ml to about 2 ng/ml and remained stable for seven years. However, over the past five years, my PSA has gradually increased and recently reached 6.6 ng/ml.The cause of this rise was unclear until MRI and biopsy tests were conducted. These confirmed an earlier diagnosis of a low-grade tumor (T1c), but also showed that the tumor had grown substantially.Dr. Shinohara expressed concern over this significant development and advised more frequent PSA checks during the next six months. If my PSA continues to climb, he plans to recommend MR imaging and possible treatment options, such as focal ablation.I am deeply grateful for the exceptional care from Dr. Shinohara and his team, especially Jaclyn Wittmer, whose support has been vital throughout my treatment journey.
- April 3, 20265 out of 5 Stars
I trust Dr. Shinohara's recommendations and experience to guide me through my prostate health.
- March 26, 20265 out of 5 Stars
Dr Shinohara is a gifted healer. I am so grateful for his care
- March 16, 20265 out of 5 Stars
Superb physician and ancillary staff
- March 12, 20265 out of 5 Stars
He seemed to be the best urologist & oncologist whom I've ever met or heard about.
- March 2, 20265 out of 5 Stars
Everything went smoothly
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.